James Aaron Balog

Person

Lambertville, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immunoregulatory agents
- Patent number 11,932,601
- Issue date Mar 19, 2024
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridinyl substituted oxoisoindoline compounds
- Patent number 11,718,601
- Issue date Aug 8, 2023
- Bristol-Myers Squibb Company
- Yan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,649,212
- Issue date May 16, 2023
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of helios protein
- Patent number 11,548,870
- Issue date Jan 10, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,447,449
- Issue date Sep 20, 2022
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,351,164
- Issue date Jun 7, 2022
- Bristol-Myers Squibb Company
- Liping Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,337,970
- Issue date May 24, 2022
- Bristol-Myers Squibb Company
- Emily Charlotte Cherney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,253,525
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoregulatory agents
- Patent number 11,242,319
- Issue date Feb 8, 2022
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,066,392
- Issue date Jul 20, 2021
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,066,383
- Issue date Jul 20, 2021
- Bristol-Myers Squibb Company
- David K. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,959,986
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,696,648
- Issue date Jun 30, 2020
- Bristol-Myers Squibb Company
- David K. Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 10,689,331
- Issue date Jun 23, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,633,342
- Issue date Apr 28, 2020
- Bristol-Myers Squibb Company
- Emily Charlotte Cherney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,544,099
- Issue date Jan 28, 2020
- Bristol-Myers Squibb Company
- Emily Charlotte Cherney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoregulatory agents
- Patent number 10,533,014
- Issue date Jan 14, 2020
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,932
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,933
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 10,323,004
- Issue date Jun 18, 2019
- Bristol-Myers Squibb Company
- Weifang Shan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoregulatory agents
- Patent number 10,206,893
- Issue date Feb 19, 2019
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 10,167,254
- Issue date Jan 1, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoregulatory agents
- Patent number 10,106,546
- Issue date Oct 23, 2018
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 9,895,330
- Issue date Feb 20, 2018
- Bristol-Myers Squibb Company
- Jay A Markwalder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 9,790,169
- Issue date Oct 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 9,765,018
- Issue date Sep 19, 2017
- Bristol-Myers Squibb Company
- Jay A. Markwalder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 9,758,492
- Issue date Sep 12, 2017
- Bristol-Myers Squibb Company
- Jay A. Markwalder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase (IDO)
- Patent number 9,675,571
- Issue date Jun 13, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoregulatory agents
- Patent number 9,643,972
- Issue date May 9, 2017
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 9,624,188
- Issue date Apr 18, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS
- Publication number 20230303527
- Publication date Sep 28, 2023
- Bristol-Myers Squibb Company
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GALECTIN-3 INHIBITORS
- Publication number 20230303538
- Publication date Sep 28, 2023
- Bristol-Myers Squibb Company
- CHUNJIAN LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS
- Publication number 20220324840
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLIGANDS FOR IMAGING THE ID01 ENZYME
- Publication number 20220305144
- Publication date Sep 29, 2022
- Bristol-Myers Squibb Company
- David J. Donnelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20220274926
- Publication date Sep 1, 2022
- Flexus Biosciences, Inc.
- Hilary Plake BECK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210355113
- Publication date Nov 18, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210299126
- Publication date Sep 30, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210290613
- Publication date Sep 23, 2021
- Bristol-Myers Squibb Company
- Emily Charlotte CHERNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210283123
- Publication date Sep 16, 2021
- Bristol-Myers Squibb Company
- Liping ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210206723
- Publication date Jul 8, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN
- Publication number 20210147383
- Publication date May 20, 2021
- Bristol-Myers Squibb Company
- Andrew P. DEGNAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210070698
- Publication date Mar 11, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200095231
- Publication date Mar 26, 2020
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069646
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069695
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME
- Publication number 20190282714
- Publication date Sep 19, 2019
- BRISTOL-MYERS SQUIBB COMPANY
- David J. Donnelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20190144416
- Publication date May 16, 2019
- Bristol-Myers Squibb Company
- David K. WILLIAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20190144417
- Publication date May 16, 2019
- Bristol-Myers Squibb Company
- David K. WILLIAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20190135758
- Publication date May 9, 2019
- Bristol-Myers Squibb Company
- Emily Charlotte CHERNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20190119216
- Publication date Apr 25, 2019
- Bristol-Myers Squibb Company
- Emily Charlotte CHERNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20190119215
- Publication date Apr 25, 2019
- Bristol-Myers Squibb Company
- Weifang SHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20190092729
- Publication date Mar 28, 2019
- Hilary Plake BECK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDO INHIBITORS
- Publication number 20190002402
- Publication date Jan 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20190002472
- Publication date Jan 3, 2019
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20180325889
- Publication date Nov 15, 2018
- Hilary Plake BECK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20180282281
- Publication date Oct 4, 2018
- Flexus Biosciences, Inc.
- Hilary Plake BECK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180079712
- Publication date Mar 22, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180072660
- Publication date Mar 15, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDO INHIBITORS
- Publication number 20170231999
- Publication date Aug 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOREGULATORY AGENTS
- Publication number 20170197973
- Publication date Jul 13, 2017
- Flexus Biosciences, Inc.
- Hilary Plake Beck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

James Aaron Balog

Person

Patents Grantslast 30 patents

Immunoregulatory agents

Pyridinyl substituted oxoisoindoline compounds

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Compounds useful as inhibitors of helios protein

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Immunoregulatory agents

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

IDO inhibitors

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Immunoregulatory agents

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Immunoregulatory agents

IDO inhibitors

Immunoregulatory agents

IDO inhibitors

IDO inhibitors

IDO inhibitors

IDO inhibitors

Inhibitors of indoleamine 2,3-dioxygenase (IDO)

Immunoregulatory agents

IDO inhibitors

Patents Applicationslast 30 patents

PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS

GALECTIN-3 INHIBITORS

PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS

RADIOLIGANDS FOR IMAGING THE ID01 ENZYME

IMMUNOREGULATORY AGENTS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

IMMUNOREGULATORY AGENTS

IDO INHIBITORS

IMMUNOREGULATORY AGENTS

IMMUNOREGULATORY AGENTS

IMMUNOREGULATORY AGENTS

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

IDO INHIBITORS

IMMUNOREGULATORY AGENTS